Vinorelbine and Gemcitabine Combinations in Advanced Non–Small-Cell Lung Cancer
- 1 November 2000
- journal article
- Published by Elsevier in Clinical Lung Cancer
- Vol. 2 (2) , 123-127
- https://doi.org/10.3816/clc.2000.n.024
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Gemcitabine Plus Vinorelbine Versus Vinorelbine Alone in Elderly Patients With Advanced Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2000
- Gemcitabine and vinorelbine in advanced nonsmall cell lung carcinomaCancer, 2000
- Phase III Trial of Gemcitabine Plus Cisplatin Versus Cisplatin Alone in Patients With Locally Advanced or Metastatic Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2000
- Phase I/II Study of Gemcitabine Plus Vinorelbine as First-Line Chemotherapy of Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2000
- Gemcitabine plus vinorelbine in nonsmall cell lung carcinoma patients age 70 years or older or patients who cannot receive cisplatinCancer, 1999
- Phase II study of vinorelbine and gemcitabine for inoperable stage IIIB-IV non-small-cell lung cancerAnnals of Oncology, 1999
- Vinorelbine/gemcitabine in advanced non-small cell lung cancer (NSCLC): a phase I trialEuropean Journal Of Cancer, 1998
- Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study.Journal of Clinical Oncology, 1998
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995